Autori: Mortato E., Artosi F., Borselli C., Compagnucci I., Rivieccio A., Lanna C., Lambiase S., Gaeta Shumak R., Loconsole F., Bianchi L., Campione E.
Bimekizumab for the treatment of moderate to severe psoriasis: a real-world experience over 52 weeks from two Italian dermatology clinics. Journal of Dermatological Treatment, 36(1), 2432932 (2025). DOI: 10.1080/09546634.2024.2432932